Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?

Gene Ther · 2025 · PMC12518134 · PMID 40181163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Therefore, the antigenic load is likely to be significant, and this factor is known to further exacerbate the unfavourable environment [ 60 ].

also in 492 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.